COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.
作者信息
Xu Fang, Carlson Susan A, Wheaton Anne G, Greenlund Kurt J
机构信息
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
出版信息
Inflamm Bowel Dis. 2021 Jun 15;27(7):1166-1169. doi: 10.1093/ibd/izab041.
Abstract
摘要
相似文献
1
COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020.2020年4月1日至7月31日美国患有炎症性肠病的医疗保险受益人的COVID-19住院情况
Inflamm Bowel Dis. 2021 Jun 15;27(7):1166-1169. doi: 10.1093/ibd/izab041.
2
Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators.新型冠状病毒肺炎对炎症性肠病临床试验招募的影响：一项针对主要研究者的全球调查
Inflamm Bowel Dis. 2021 Jul 27;27(8):e98. doi: 10.1093/ibd/izab111.
3
Hospitalizations for Inflammatory Bowel Disease Among Medicare Fee-for-Service Beneficiaries - United States, 1999-2017.医疗保险按服务收费受益人的炎症性肠病住院治疗情况-美国，1999-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Dec 13;68(49):1134-1138. doi: 10.15585/mmwr.mm6849a2.
4
Worse impact of second wave COVID-19 pandemic in adults but not in children with inflammatory bowel disease: an Italian single tertiary center experience.第二次 COVID-19 大流行对成年人的影响更严重，但对炎症性肠病儿童没有影响：意大利一家三级医学中心的经验。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2744-2747. doi: 10.26355/eurrev_202103_25437.
5
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.2019 年冠状病毒病的自然史：2600 多万美国医疗保险受益人的住院和死亡风险因素。
J Infect Dis. 2021 Mar 29;223(6):945-956. doi: 10.1093/infdis/jiaa767.
6
Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.美国炎症性肠病患者发生重症2019冠状病毒病的风险：一项多中心研究网络研究
Gastroenterology. 2020 Oct;159(4):1575-1578.e4. doi: 10.1053/j.gastro.2020.06.003. Epub 2020 Jun 6.
7
Stroke Hospitalizations Before and During COVID-19 Pandemic Among Medicare Beneficiaries in the United States.美国医疗保险受益人群在新冠疫情前后的中风住院情况。
Stroke. 2021 Nov;52(11):3586-3601. doi: 10.1161/STROKEAHA.121.034562. Epub 2021 Jul 29.
8
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.炎症性肠病中 SARS-CoV-2 感染的低流行率。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2418-2424. doi: 10.26355/eurrev_202103_25283.
9
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.英国一家大型城市医疗信托机构中血液系统恶性肿瘤合并新型冠状病毒肺炎感染住院患者的结局
Leuk Lymphoma. 2021 Feb;62(2):469-472. doi: 10.1080/10428194.2020.1838506. Epub 2020 Nov 9.
10
Inflammatory Bowel Disease Hospitalizations Are Similar for Patients Receiving Televisit-Delivered Outpatient Care and Those Receiving Traditional In-Person Care.接受远程门诊服务的患者和接受传统门诊服务的患者的炎症性肠病住院情况相似。
Am J Gastroenterol. 2024 Aug 1;119(8):1555-1562. doi: 10.14309/ajg.0000000000002703. Epub 2024 Feb 5.
引用本文的文献
1
Incidence of Severe COVID-19 Outcomes and Immunization Rates in Apulian Individuals with Inflammatory Bowel Disease: A Retrospective Cohort Study.普利亚地区炎症性肠病患者中重症 COVID-19 结局的发生率及免疫接种率：一项回顾性队列研究
Vaccines (Basel). 2024 Aug 2;12(8):881. doi: 10.3390/vaccines12080881.
2
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.全球范围内胃肠病学家和医疗保健提供者在促进炎症性肠病患者 COVID-19 免疫接种中的作用：系统评价和荟萃分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16.
3
The association between ulcerative colitis and COVID-19 severity: a systematic review and meta-analysis systematic review.溃疡性结肠炎与 COVID-19 严重程度的关联：系统评价和荟萃分析。
Int J Colorectal Dis. 2023 Dec 18;39(1):5. doi: 10.1007/s00384-023-04568-6.
4
COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis.全球炎症性肠病患者的COVID-19免疫接种率：一项系统评价和荟萃分析
Vaccines (Basel). 2023 Sep 25;11(10):1523. doi: 10.3390/vaccines11101523.
5
Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.炎症性肠病与 COVID-19 结局：荟萃分析。
Sci Rep. 2022 Dec 9;12(1):21333. doi: 10.1038/s41598-022-25429-2.
6
Missing science: A scoping study of COVID-19 epidemiological data in the United States.缺失的科学：美国 COVID-19 流行病学数据的范围研究。
PLoS One. 2022 Oct 12;17(10):e0248793. doi: 10.1371/journal.pone.0248793. eCollection 2022.
Zotero 插件